Open Access

Hypertriglyceridaemia as a Causal Factor and Target for Therapy.

Presentation

About the speaker

Professor Borge Nordestgaard

Herlev and Gentofte Hospital, Copenhagen (Denmark)
8 presentations
1 follower

4 more presentations in this session

Welcome and Introductions, Program Overview.

Speaker: Professor P. Steg (Paris, FR)

Thumbnail

Clinical Trial Evidence of Omega-3 Fatty Acids in ASCVD.

Speaker: Professor P. Steg (Paris, FR)

Thumbnail

Practical Considerations on Using Omega-3 Fatty Acids to Prevent ASCVD.

Speaker: Professor B. Nordestgaard (Copenhagen, DK)

Thumbnail

Live Q&A and Adjourn.

Speaker: Professor P. Steg (Paris, FR) Professor B. Nordestgaard (Copenhagen, DK)

Thumbnail

Access the full session

Clinical Update on Managing Hypertriglyceridaemia with Omega-3 Fatty Acid Icosapent Ethyl

Speakers: Professor B. Nordestgaard, Professor P. Steg, Professor P. Steg, Professor B. Nordestgaard, Professor P. Steg...
Thumbnail

About the event

Image

ESC CONGRESS 2020 - The Digital Experience

28 August - 1 September 2020

Sessions Presentations

Related content

ESC Premium Access

Effects of Sacubitril/valsartan compared with ramipril on coronary events after myocardial infarction - Results from the PARADISE-MI Trial

27 August 2021

ESC Premium Access

BIC-8 Revisited - Copeptin together with high sensitivity troponin for managemnent of suspected NSTE-ACS

27 August 2021

ESC Premium Access

Refining dual antithrombotic treatment in patients with chronic coronary syndrome

27 August 2021

This platform is supported by

logo Novo Nordisk